6.5.2026: Malignant tumor treatment remains a major challenge due to the limited precision and significant side effects. Copper-based single-atom nanozymes have shown promise for tumor microenvironment-responsive precision therapy, but their practical application is limited by weak substrate adsorption, difficulty in synthesizing low-coordination unsaturated structures, and limitations of conventional preparation methods.
7.12.2015: Currently, we solve three main tasks using Arabidopsis thaliana as model: 1. Genetic determination of metabolome pathway connected to prenylflavonoid and lupulin production in hop. 2. Study of...
3.3.2026: Join industry experts for the 6th annual Future Labs, Automation & Technology Summit East to hear real-world strategies for scaling innovation, cost reduction, scalability, interoperability, and...
3.5.2017: A Slovenian research institute developed protein patches applicable for healing chronic skin wounds rapidly and cost efficiently. Patches are biodegradable – disappearing in the wound, leaving no...
11.8.2014: Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech industries, Pharma-Biotech Product and Company Valuation with Dr. Patrik Frei!
Having the status of the official portal for Czech biotechnology, Gate2Biotech serves to biotechnology companies, suppliers, investors, institutions, students and general public interested in biotechnology.
The portal is dedicated to the following subjects: plant and animal ...
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2026 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology projecst no.10 - 10th page of our biotechnology projects database
Biotechnology legislative - Biotech legislative environment search
Tiny viral switch offers hope against drug-resistant bacteria
A biochip built for the next pandemic can test dozens of viral antigens at once